Oral cancer is a significant global health concern, ranking among the most common malignancies worldwide, with particularly high incidence rates in developing countries. Despite substantial progress in diagnostic techniques and treatment options, the mortality rate associated with oral cancer remains persistently high. This is primarily due to delayed diagnosis, limited public awareness, and prevalent lifestyle risk factors such as tobacco and alcohol use, as well as human papillomavirus (HPV) infection. Early-stage oral cancer is often asymptomatic, and many patients present with advanced disease, making successful treatment more challenging. This report examines the current trends in oral cancer, with a focus on the challenges encountered in its management and the advancements being made in the field. It highlights the critical epidemiological factors that contribute to the high burden of the disease, including demographic variations, geographical disparities, and the growing impact of HPV-related cancers. Additionally, the report delves into the risk factors that predispose individuals to oral cancer, such as tobacco use, alcohol consumption, poor oral hygiene, and chronic infections. One of the central topics discussed is early detection, where advancements in diagnostic techniques such as salivary biomarkers, optical imaging, and molecular screening are explored. These technologies hold the potential to improve early-stage detection rates, enabling timely intervention and better outcomes. Furthermore, the report reviews the latest therapeutic interventions, including surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapies. Minimally invasive surgical techniques, advanced reconstruction methods, and novel drug therapies are transforming the landscape of oral cancer treatment, leading to improved survival rates and better quality of life for patients. The report also outlines future perspectives in oral cancer management, emphasizing prevention strategies through public health initiatives, the need for innovative research into biomarkers and treatment options, and the integration of artificial intelligence (AI) in diagnostics and personalized care. Finally, the importance of global collaboration in tackling the challenges of oral cancer is underscored, with recommendations for increasing awareness, improving access to care, and fostering research partnerships. In conclusion, while the burden of oral cancer remains high, ongoing advancements in early detection, treatment modalities, and research offer hope for improved patient outcomes. A concerted effort in prevention, early intervention, and personalized care, coupled with technological innovations and global collaboration, can significantly reduce the global impact of oral cancer, ultimately improving survival rates and quality of life for affected individuals.